The NCTAP was finalized as part of CMS’ fourth COVID-19 interim final rule. A version of this article was first published February 10, 2021, by HCPro's Revenue Cycle Advisor, a sibling publication to ...
CMS will make significant changes to ASC and outpatient surgery reimbursement next year. In the 2026 Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Final Rule, published ...
CPT copyright 2010 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.The following Q&A comes from ...
CMS’ final rule released Nov. 1 includes changes to the billing and coding requirements for evaluation and management services, Health Data Management reports. Effective Jan. 1, CMS’ E/M coding ...
CMS suggests 1,495 total changes to the ICD-10-CM diagnosis code set in the FY 2023 IPPS proposed rule. Brain illness and injury, with a focus on dementia-related diagnoses, occupy a high volume of ...
The Centers for Medicare and Medicaid Services is delaying for two years implementation of evaluation and management coding reforms that affect physician payment, in a move applauded by the American ...
Federal regulators have said that healthcare pricing data, which hospitals and insurers must make public under new requirements, should not be blocked from web searches, according to an April 14 Wall ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
This year ushered in many changes affecting reimbursement for healthcare providers, but few are as important as the new Physician Fee Schedule from the Centers for Medicare & Medicaid Services (CMS) ...
If you listen to the Centers for Medicare & Medicaid Services (CMS), the organization's plans to update evaluation and management (E/M) codes could simplify documentation and free up doctors’ time to ...
Biomedical innovators have mobilized across the world to address COVID-19, from the initiation of clinical trials for potential vaccines to ongoing studies of repurposed medications for potential ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback